GlassScriptPhysician profile
Jason M Jack
NPI 1518910892
$3,925.80
in general payments reported to CMS, 2019-2025
14 companies · $357 in 2025
The $357 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $260 · 2020: $163 · 2021: $1,026 · 2022: $785 · 2023: $543 · 2024: $792 · 2025: $357.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,693.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,692.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $889.59 | 2019-2022 | |
| Sientra, INC. | $851.21 | 2019-2022 | |
| Integra Lifesciences Corporation | $403.46 | 2023-2024 | Integra, Durasorb Monofilament Mesh, Integra Dermal Regeneration Template |
| Abbvie INC. | $382.45 | 2023-2025 | |
| Mentor Worldwide LLC | $341.21 | 2020-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Tela Bio, INC. | $276.11 | 2024-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Elutia, INC. | $200.00 | 2022 | |
| Avita Medical Americas, LLC | $155.69 | 2025 | Cohealyx, Permeaderm, Recell |
| Musculoskeletal Transplant Foundation INC. | $127.50 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $114.52 | 2024-2025 | Exparel |
| Motiva USA, LLC | $80.02 | 2024-2025 | |
| Tei Biosciences INC | $42.55 | 2019 | |
| Galderma Laboratories, L.P. | $35.02 | 2019-2023 | |
| Davol INC. | $26.47 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Jack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.